Concepedia
Statistics
Publications
12
Citations
2.2K
H-Index
11
Active since
2017
Affiliations
University of Oxford(Current)
King's College London
University College London
Oxford University Clinical Research Unit
University of Nottingham
Jill Deane is an author at University of Oxford specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.
Publications per year
2017–2025
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
1–5 of 12